X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUVEN LIFE - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUVEN LIFE ABBOTT INDIA/
SUVEN LIFE
 
P/E (TTM) x 32.3 16.6 194.7% View Chart
P/BV x 8.1 3.1 262.1% View Chart
Dividend Yield % 0.8 1.2 68.4%  

Financials

 ABBOTT INDIA   SUVEN LIFE
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
SUVEN LIFE
Mar-16
ABBOTT INDIA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs6,015339 1,777.0%   
Low Rs3,707144 2,567.2%   
Sales per share (Unadj.) Rs1,236.939.2 3,151.7%  
Earnings per share (Unadj.) Rs122.27.5 1,637.5%  
Cash flow per share (Unadj.) Rs129.08.8 1,469.8%  
Dividends per share (Unadj.) Rs35.002.00 1,750.0%  
Dividend yield (eoy) %0.70.8 86.9%  
Book value per share (Unadj.) Rs521.249.0 1,063.8%  
Shares outstanding (eoy) m21.25127.28 16.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.96.2 63.9%   
Avg P/E ratio x39.832.4 123.0%  
P/CF ratio (eoy) x37.727.5 137.0%  
Price / Book Value ratio x9.34.9 189.2%  
Dividend payout %28.626.8 106.9%   
Avg Mkt Cap Rs m103,29630,732 336.1%   
No. of employees `0003.01.0 309.9%   
Total wages/salary Rs m3,370416 809.3%   
Avg. sales/employee Rs Th8,891.85,236.1 169.8%   
Avg. wages/employee Rs Th1,140.0436.5 261.2%   
Avg. net profit/employee Rs Th878.3995.5 88.2%   
INCOME DATA
Net Sales Rs m26,2844,995 526.2%  
Other income Rs m504194 260.7%   
Total revenues Rs m26,7895,189 516.3%   
Gross profit Rs m3,6651,233 297.4%  
Depreciation Rs m144167 86.4%   
Interest Rs m854 14.9%   
Profit before tax Rs m4,0171,205 333.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,421255 557.3%   
Profit after tax Rs m2,596950 273.4%  
Gross profit margin %13.924.7 56.5%  
Effective tax rate %35.421.2 167.1%   
Net profit margin %9.919.0 52.0%  
BALANCE SHEET DATA
Current assets Rs m14,4464,986 289.7%   
Current liabilities Rs m4,7251,042 453.3%   
Net working cap to sales %37.079.0 46.8%  
Current ratio x3.14.8 63.9%  
Inventory Days Days5161 84.3%  
Debtors Days Days2039 50.0%  
Net fixed assets Rs m1,1133,126 35.6%   
Share capital Rs m213127 166.9%   
"Free" reserves Rs m10,8083,717 290.7%   
Net worth Rs m11,0766,236 177.6%   
Long term debt Rs m0432 0.0%   
Total assets Rs m16,2418,079 201.0%  
Interest coverage x497.023.2 2,139.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.60.6 261.8%   
Return on assets %16.012.4 129.1%  
Return on equity %23.415.2 153.9%  
Return on capital %36.318.9 192.5%  
Exports to sales %0.687.5 0.7%   
Imports to sales %12.612.2 103.4%   
Exports (fob) Rs m1624,371 3.7%   
Imports (cif) Rs m3,322611 543.9%   
Fx inflow Rs m2684,666 5.7%   
Fx outflow Rs m3,927942 416.9%   
Net fx Rs m-3,6593,724 -98.3%   
CASH FLOW
From Operations Rs m2,514922 272.7%  
From Investments Rs m-800-619 129.1%  
From Financial Activity Rs m-803-698 115.0%  
Net Cashflow Rs m912-396 -230.5%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 36.5 46.8%  
Shareholders   18,270 37,287 49.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   TORRENT PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  PFIZER  ALEMBIC PHARMA  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Infosys Woes, Insurance IPOs and Top Stocks in Action(Pre-Open)

On Monday, the share markets in India slumped in the final hours of trade and finished the day in red.The BSE Sensex closed lower by 266 points to end at 31,259.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 21, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS